Value drivers of development stage biopharma companies

OBJECTIVE: Scholars previously estimated research and development (R&D) costs of the internal drug development process. However, little is known about the costs and value arising from externally acquired therapeutics. This study identifies and estimates the magnitude of factors associated with B...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaeli, Daniel Tobias, Yagmur, Hasan Basri, Achmadeev, Timur, Michaeli, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550717/
https://www.ncbi.nlm.nih.gov/pubmed/35038054
http://dx.doi.org/10.1007/s10198-021-01427-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550717/
https://www.ncbi.nlm.nih.gov/pubmed/35038054
http://dx.doi.org/10.1007/s10198-021-01427-5

Ejemplares similares